Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Drivers
     3.1 Increasing Incidence of Chronic Diseases
     3.2 Increased Affordability
     3.3 Benefits over Conventional Drug Delivery Devices
     3.4 Expansion in Emerging Markets

4. Challenges
     4.1 High Prices
     4.2 Testing and Regulatory Issues
     4.3 Low Awareness

5. Regulatory Landscape
     5.1 US
     5.2 Europe
     5.3 Japan
     5.4 China
     5.5 India

6. Needle Free Drug Delivery Market Outlook to 2020
     6.1 Current Market size and Future Outlook

7. Market Segmentation
     7.1 By Technology
            7.1.1 Oral Drug Delivery System
            7.1.2 Inhaler Drug Delivery System
            7.1.3 Transdermal Drug Delivery System
            7.1.4 Jet injector Drug Delivery System
            7.1.5 Micro Needle Drug Delivery System
     7.2 By Application
     7.3 By geography

8. Industry Trends
     8.1 Introduction of Low Cost Inhalers for Developing Countries
     8.2 Innovation in Advanced Dry Powder Inhalers
     8.3 Oral Drug Delivery System goes Electrical
     8.4 Consolidation in the Market

9. Competitor Profiles
     9.1 Mylan Inc.
     9.2 3M (MMM)
     9.3 Novatis
     9.4 AstraZeneca Plc
     9.5 Antares Pharma, Inc.
     9.6 GlaxoSmithKline Plc (GSK)
     9.7 Sanofi
     9.8 Boehringer Ingelheim GmbH
     9.9 Merck & Co.